Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Is FOXO4-DRI approved for human use
Injection site reactions(redness or discomfort) No major adverse reactions have been reported in studies, but more research is needed to fully understand its safety profile
Qin S, Huang L, Gong J, et al
DSIP is under active research for potential application in: Individuals with insomnia or light, fragmented sleep Those with chronic stress or HPA axis dysfunction Athletes and biohackers seeking enhanced recovery People working night shifts or experiencing circadian misalignment Adults with low growth hormone output or reduced sleep efficiency Patients with PTSD or trauma-related sleep disruption (research ongoing) DSIP is not FDA-approved for any medical condition and should only be used in research settings under supervision
